Tech Talk: Mobile app can improve mood, subjective cognitive decline
Remepy, a company that is pioneering the use of hybrid treatments -- a drug plus a digital intervention - has developed a mobile app shown in clinical studies to modulate the brain and immune system and improve mood in adults with subjective cognitive decline. The app, RMPY-008, delivers a structured digital protocol that combines evidence-based psychological interventions with neuroscience-informed sensory modulation.
This is a benefit of membership. If you are not an ICAA member you will need to purchase a membership for access. To learn more here
